```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 4259 Introduced in Senate (IS)]

<DOC>

116th CONGRESS
  2d Session
                                S. 4259

    To codify a statutory definition for long-term care pharmacies.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 22, 2020

Mr. Scott of South Carolina (for himself and Mr. Warner) introduced the 
 following bill; which was read twice and referred to the Committee on 
                                Finance

_______________________________________________________________________

                                 A BILL

 
    To codify a statutory definition for long-term care pharmacies.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Long-Term Care Pharmacy Definition 
Act of 2020''.

SEC. 2. DEFINITION.

    Section 1860D-2 of the Social Security Act (42 U.S.C. 1395w-102) is 
amended by adding at the end the following new subsection:
    ``(f) Long-Term Care Pharmacy Defined.--
            ``(1) In general.--The term `long-term care pharmacy' means 
        a pharmacy licensed under applicable State law that is able to 
        provide enhanced pharmacy and clinical services to individuals 
        who require enhanced medication services and reside in a 
        facility (as defined in paragraph (4)).
            ``(2) Enhanced pharmacy and clinical services.--As used in 
        this subsection, the term `enhanced pharmacy and clinical 
        services' includes--
                    ``(A) medications dispensed pursuant to a 
                prescription or chart order in specialized packaging 
                which shall include unit of use packaging, unit dose 
                packaging, single use containers, packaging from remote 
                automated dispensing technology, or other packaging 
                required;
                    ``(B) drug utilization review to identify potential 
                adverse drug reactions and inappropriate drug usage;
                    ``(C) medication reconciliation services at the 
                transition of care and other necessary clinical 
                management and medication services;
                    ``(D) timely medication delivery 24 hours a day, 7 
                days a week;
                    ``(E) pharmacist on-call availability to provider 
                dispensing and clinical services 24 hours a day, 7 days 
                a week;
                    ``(F) emergency supplies of medication as permitted 
                by law and as required, including emergency kits or 
                remote automated dispensing technology at a facility; 
                and
                    ``(G) such other services as the Secretary 
                determines appropriate.
            ``(3) Individuals requiring enhanced medication services.--
        As used in this subsection, the term `individual who requires 
        enhanced medication services' means an individual who has one 
        or more comorbid and medically complex chronic conditions that 
        are life-threatening or significantly limit overall health or 
        function, pose a high risk of hospitalization or other adverse 
        health outcomes, and require enhanced pharmacy and clinical 
        services.
            ``(4) Facility.--As used in this subsection, the term 
        `facility' includes a facility described in section 1819(a), 
        1919(a), or 1905(d), or any other setting in which individuals 
        who require enhanced medication services reside as determined 
        by the Secretary.''.
                                 <all>
```